Pregabalin prescribing data reveals ‘huge potential for harm’

Patients are frequently given concomitant scripts for opioids, researchers warn

Nearly 40% of pregabalin scripts written since its PBS subsidisation for neuropathic pain have been coprescribed with opioids despite the safety risks, a review of GP data suggests.

Use of pregabalin shot up eightfold between 2013, when it was subsidised, and 2018, say the researchers from UNSW Sydney and NPS MedicineWise.